Results of the Notice and Comment Period on Incremental Reforms to the Compendium of Policies, Guidelines and Procedures
On December 4, 2015, the PMPRB announced the start of a Notice and Comment initiative to seek stakeholder feedback on two proposed amendments to the Compendium of Policies, Guidelines and Procedures: the “Reasonable ... Read More
News & Events
05
Aug2016
29
Jul2016
PDCI’s PMPRB Guidelines Modernization Webinar Session
On June 24, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”. The paper, the initial phase of a three-part Guideline modernization process, asserts that PMPRB’s current framework is outdated and seeks feedback on a wide range ... Read More
21
Jul2016
Correction to the below TargetPharma (“PMPRB 2015 Annual Report”) sent out on July 21, 2016.
The PMPRB report tabled in Parliament was their report with respect to the Access to Information Act and to the Privacy Act and not the anticipated “2015 PMPRB Annual Report” which was not tabled and now ... Read More
12
Jul2016
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of June 30, 2016:
33 negotiations are currently underway with 8 files (including 2 biosimilars) added since the last update of May 31, 2016:
Abilify (aripiprazole): used for the treatment of schizophrenia and related ... Read More
04
Jul2016
PMPRB Guideline Modernization – PDCI to hold Industry Information Sessions in August / September
/ PMPRB, What's New
On June 24, the PMPRB released its long awaited consultation paper “PMPRB Guidelines Modernization – Discussion Paper, June 2016”. The paper, the initial phase of a three-part Guideline modernization process, asserts that PMPRB’s current framework is outdated and seeks feedback on a wide range of issues that will inform ... Read More
27
Jun2016
PMPRB – Discussion Paper Released – Board Down to 2 Board Members as of June 27 – 2015 Annual Report Board Delayed
/ PMPRB, What's New
Discussion Paper. On Friday June 24, the PMPRB released a long delayed discussion paper covering a wide range of issues that go to the core of the PMPRB’s price regulation mandate. The PMPRB will be seeking input from stakeholders over the Summer/Fall of 2016 and will hold public policy hearings ... Read More
20
Jun2016
In February 2015, PDCI Market Access (PDCI) released a report entitled pCPA Negotiation Guidelines. That report, which was a collaboration between the pan-Canadian Pharmaceutical Alliance (pCPA) and PDCI, was meant to provide guidance to manufacturers on pCPA’s expectations surrounding negotiations.
Although the pCPA Negotiation Guidelines report outlined how manufacturers should ... Read More
03
Jun2016
The British Columbia PharmaCare (BC PharmaCare) is modernizing the Reference Drug Program (RDP). Effective immediately, transitional coverage is in place to allow affected patients to switch drugs, if needed, to retain full PharmaCare coverage. During transition, PharmaCare will cover all Modernized RDP fully covered drugs and all original RDP fully ... Read More
01
Jun2016
The Régie de l’assurance maladie du Québec (RAMQ) is scheduled to release its June update of the List of Medications on June 13, 2016 which will come into effect on June 15, 2016.
For more information and to see the list update schedule, please visit the RAMQ website.
26
May2016
Effective immediately, CADTH will be formally engaging with the pan-Canadian Pharmaceutical Alliance (pCPA) and will be including the pCPA office in the CADTH Common Drug Review (CDR) and pan-Canadian Oncology Drug Review (pCODR) processes. This will provide an opportunity for the pCPA office to receive relevant information on drugs reviewed ... Read More